Advanced Cell Technology (ACTC.OB) issued broad patent in China

Home > NASDAQ: ACTC.OB, Patent Issuance, Stem Cell Research > Advanced Cell Technology (ACTC.OB) issued broad patent in China

Advanced Cell Technology (ACTC.OB) issued broad patent in China

March 23rd, 2011 Henry McCusker Leave a comment Go to comments

China’s State Intellectual Property Office has allowed the patent application to provide broad intellectual property protection in China for the manufacturing and pharmaceutical preparations of retinal pigment epithelial cells from human embryonic stem cells.

This Chinese patent filing provides coverage of the scalable manufacturing of human RPE cells from hESCs.

The Bottom Line: The claims cover methods for producing purified preparations of RPE cells from hESCs, and the use of those hESC-derived RPE cells in pharmaceutical preparations and compositions.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.